论文部分内容阅读
目的:研究盐酸利托君与硫酸镁治疗前置胎盘的临床疗效。方法:选取该院在2012年8月至2015年1月收治的84例前置胎盘孕妇的临床资料,将孕妇随机分为两组,每组各有孕妇42例,观察组采用盐酸利托君治疗,对照组采用硫酸镁治疗,比较两组孕妇的孕期时间延长、阴道出血停止、保胎成功率、新生儿体重与不良反应发生情况。结果:1观察组的保胎成功、阴道出血停止率高于对照组,对比有统计学意义(P<0.05)。2观察组的新生儿体重、孕周期延长均高于对照组,对比存在统计学意义(P<0.05)。3两组患者在不良反应率上无统计学意义(P>0.05)。结论:在前置胎盘的治疗中,临床可经盐酸利托君进行治疗,宫缩抑制效果显著,止血作用更加确切,值得临床推广应用。
Objective: To study the clinical efficacy of Rituximab and magnesium sulfate in the treatment of placenta previa. Methods: The clinical data of 84 pregnant women with placenta previa admitted from August 2012 to January 2015 in our hospital were selected. The pregnant women were randomly divided into two groups with 42 pregnant women in each group. The observation group was treated with Rituxan Hydrochloride The patients in the control group were treated with magnesium sulfate. The pregnant women ’s duration of pregnancy, the termination of vaginal bleeding, the success rate of miscarriage, neonatal weight and adverse reactions were compared between the two groups. Results: 1 The success rate of miscarriage in the observation group and the stopping rate of vaginal bleeding were higher than those in the control group, with statistical significance (P <0.05). 2 The weight of the newborn and the prolongation of the gestation period in the observation group were all higher than those in the control group, with statistical significance (P <0.05). 3 The two groups of patients in the adverse reaction rate was not statistically significant (P> 0.05). Conclusion: In the treatment of placenta previa, the clinical treatment with ritodrine hydrochloride, tocolysis suppression effect is significant, the role of hemostasis more precise, worthy of clinical promotion and application.